Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Amit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tel Aviv University SacklerClass of 2007
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2018 - 2026
IL State Medical License 2019 - 2023
Clinical Trials
- Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions Start of enrollment: 2022 Sep 13
Roles: Contact, Principal Investigator
- Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy Start of enrollment: 2024 Apr 16
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Ushering in Neoadjuvant Immune Checkpoint Inhibitors for Mucosal Head and Neck Squamous Cell Carcinoma.Melina J Windon, Nabil F Saba, Moran Amit
JAMA Otolaryngology-- Head & Neck Surgery. 2025-04-24 - International multispecialty expert physician preoperative identification of extranodal extension in patients with oropharyngeal cancer using computed tomography: Pros...Onur Sahin, Serageldin Kamel, Kareem A Wahid, Cem Dede, Nicolette Taku
Cancer. 2025-04-01 - Integrating priorities at the intersection of cancer and neuroscience.William L Hwang, Ella N Perrault, Alexander Birbrair, Brandi J Mattson, David H Gutmann
Cancer Cell. 2025-01-13
Press Mentions
MD Anderson Research Highlights: ASCO 2024 Special EditionMay 23rd, 2024
Absent p53, Oral Cancers Reprogram Nerves to Fuel Tumor GrowthMarch 20th, 2020- Absent p53, Oral Cancers Recruit and Reprogram Nerves to Fuel Tumor GrowthFebruary 15th, 2020
- Join now to see all
Grant Support
- Harnessing the nervous system to overcome resistance to immunotherapy in oral cancerUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2026
- Harnessing the nervous system to overcome resistance to immunotherapy in oral cancerUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2026
- Harnessing the nervous system to overcome resistance to immunotherapy in oral cancerUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2026
- Cancer Neuroscience - An Emerging HallmarkUNIVERSITY OF TX MD ANDERSON CAN CTR2024–2025
- Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment ResistanceUNIVERSITY OF TX MD ANDERSON CAN CTR2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
